Lakefront Biotherapeutics NV (AMS:LKFT)
23.96
+0.08 (0.34%)
Sep 16, 2026, 5:35 PM CET
Lakefront Biotherapeutics NV Employees
Lakefront Biotherapeutics NV had 196 employees as of June 30, 2026. The number of employees decreased by 256 or -56.64% since the number was reported on December 31, 2025.
Employees
196
Change
-256
Growth
-56.64%
Revenue / Employee
€5,053,949
Profits / Employee
€3,044,061
Market Cap
1.55B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 196 | -256 | -56.64% |
| Dec 31, 2025 | 452 | -252 | -35.80% |
| Dec 31, 2024 | 704 | -419 | -37.31% |
| Dec 31, 2023 | 1,123 | -215 | -16.07% |
| Dec 31, 2022 | 1,338 | 29 | 2.22% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Signify | 25,866 |
| Havas | 22,960 |
| Fugro | 10,000 |
| Basic-Fit | 7,906 |
| Koninklijke Heijmans | 6,361 |
| TKH Group | 6,151 |
| AMG Critical Materials | 3,500 |
| Corbion | 2,363 |
Lakefront Biotherapeutics NV News
- 1 day ago - Lakefront Biotherapeutics NV Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 1 day ago - Acquisition of Own Shares - GlobeNewsWire
- 8 days ago - Acquisition of Own Shares - GlobeNewsWire
- 8 days ago - Lakefront to Present at the Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewsWire
- 15 days ago - Acquisition of Own Shares - GlobeNewsWire
- 23 days ago - Lakefront Biotherapeutics granted orphan drug designation for gamgertamig - TheFly
- 23 days ago - U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus - GlobeNewsWire
- 23 days ago - Lakefront Receives Transparency Notification from Bank of America - GlobeNewsWire